Juliet Tammenoms - Jul 29, 2021 Form 3 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 10:42 AM
Previous filing
May 19, 2021
Next filing
Aug 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RXST Series G Preferred Stock Jul 29, 2021 Common Stock 1.61M See footnote F1, F2
holding RXST Series H Preferred Stock Jul 29, 2021 Common Stock 242K See footnote F2, F3
holding RXST Warrant (right to buy) Jul 29, 2021 Series H Preferred Stock 36.3K $12.40 See footnote F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.
F2 Shares and warrant held by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II Patrick G. Enright and the Reporting Person are managing members of LCP II and may be deemed to share voting and investment power over the securities held by LVP II, LCP II and each of Mr. Enright and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
F3 All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.
F4 The warrant shall be automatically exercised immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

Remarks:

Exhibit 24 - Power of Attorney